Publications en collaboration avec des chercheurs de Hebrew University of Jerusalem (1)

2022

  1. MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S303-S304